Take Action Publications Press Room About Public Citizen Public Citizen Divisions Home
Promoting safer drugs and public health

JOIN US! |Take Action | Publications | About Health Research | Contact Us
Public Citizen's ranking of state Medicaid programs
Search

For Keyword(s)
advanced search

Email Signup

Sign up for our free activist updates.


Publications:

»

(10/29/08) Petition to Immediately Ban Diabetes Drug Rosiglitazone (AVANDIA) (HRG Publication #1848)

»

(7/30/07) Testimony Before the FDA Advisory Committee Meeting on Rosiglitazone (HRG Publication #1820)

»

(5/22/07) Letter Demonstrating that the FDA Knew About Avandia Dangers, Urging Action (HRG Publication #1812)

»

(11/18/05) Letter to FDA urging that the diabetes drug muraglitazar (PARGLUVA) not be approved because of an increased risk of serious adverse reactions including death (HRG Publication #1756)

»

(9/9/05) Testimony before FDA Advisory Committee on new diabetes drug Muraglitazar (PARGLUVA): Risks outweigh the benefits. (HRG Publication #1749)

»

(7/26/01) Testimony before the Food and Drug Administration Endocrine and Metabolic Drugs Advisory Committee Meeting on pramlintide (Symlin), recommending that it not be approved and that no additional clinical trials be done (HRG Publication #1584)

»

(7/15/00) Letter sent to the Lancet on availability of information on thiazolidinediones. (HRG Publication #1534)

»

(3/7/00) Petition to the Food and Drug Administration requesting that it immediately require labeling for the diabetes drugs troglitazone (Rezulin), rosiglitazone (Avandia) and pioglitazone (Actos)(HRG Publication #1514)

»

(3/26/99) Statement before the Food and Drug Administration Endocrine and Metabolic Drugs Advisory Committee meeting advising them to withdraw troglitazone from the U.S. Market. (HRG Publication #1476)

»

(7/27/98) Petition to the Food and Drug Administration to ban troglitazone/Rezulin due to its causing several cases of liver failure. (HRG Publication #1449)


more resources

 

    » hrg | drugs | diabetes


Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.


Join | Contact PC | Contribute | Site Map | Careers/Internships| Privacy Statement